Screening for Uterine Cavity Abnormalities in Women Scheduled for IVF
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
El enlace se guarda en el portapapeles.
EstadoTerminado
Patrocinadores
Assiut University
ENSAYO CLÍNICO: NCT02598921
BioSeek: NCT02598921
Palabras clave
Abstracto
Evaluation of the endometrial cavity is an important step in the infertility work-up, particularly if assisted reproductive therapy is planned. The aim is to identify possible endometrial abnormalities that may impair implantation.Undiagnosed endometrial abnormalities are present in 11 to 45% of women scheduled for in vitro fertilization (IVF).Traditionally, two dimensional transvaginal ultrasound (2D TVUS) and hysterosalpingography (HSG) are the basic methods for assessment of the endometrial cavity. However, these imaging modalities have shown high false negative rates among infertile women, a finding that could confine their rule to initial screening rather than definite diagnosis.
Office hysteroscopy (OH) is the gold standard for evaluation of the endometrial cavity. Although the endoscopic approach has been proven to increase pregnancy rate in women who experienced prior implantation failure, evidence on treatment of unsuspected hysteroscopically-diagnosed endometrial lesions, to improve IVF outcome, is still lacking. Nevertheless,clinicians tend to use OH routinely prior to IVF because the psychological and financial burden that infertile couples may experience as a consequence of failed IVF cycle is unjustifiable.Yet, costs and invasiveness of OH counteract its global implementation to all women prior to IVF.
fechas
Verificado por última vez: | 09/30/2013 |
Primero enviado: | 11/04/2015 |
Inscripción estimada enviada: | 11/04/2015 |
Publicado por primera vez: | 11/05/2015 |
Última actualización enviada: | 12/15/2015 |
Última actualización publicada: | 12/16/2015 |
Fecha de inicio real del estudio: | 06/30/2014 |
Fecha estimada de finalización primaria: | 07/31/2015 |
Fecha estimada de finalización del estudio: | 09/30/2015 |
Condición o enfermedad
Infertility
Intervención / tratamiento
Radiation: Three dimensional ultrasound
Device: Office hysteroscopy
Fase
Fase 2
Grupos de brazos
Brazo | Intervención / tratamiento |
---|---|
Other: Three dimensional ultrasound Three dimensional ultrasound evaluated the uterine cavity for cavitary lesions | Radiation: Three dimensional ultrasound |
Other: Office hysteroscopy Office hystrescopy evaluated the uterine cavity for cavitary lesions | Device: Office hysteroscopy |
Criterio de elegibilidad
Edades elegibles para estudiar | 20 Years A 20 Years |
Sexos elegibles para estudiar | Female |
Acepta voluntarios saludables | si |
Criterios | Inclusion Criteria: - History of primary infertility - Normal uterine cavity on HSG - Women were selected for IVF therapy. Exclusion Criteria: - Women with known diagnosis of uterine abnormality by office hysteroscopy |
Salir
Medidas de resultado primarias
1. Number of patients who have cavitary lesion by three dimensional ultrasound [1 year]